{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:16:21Z","timestamp":1789614981943,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijcard.2021.01.060","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T17:17:40Z","timestamp":1612113460000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States"],"prefix":"10.1016","volume":"331","author":[{"given":"Suchith","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaqib H.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulino","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.01.060_bb0005","article-title":"National Burden of heart failure events in the United States, 2006 to 2014","volume":"11","author":"Jackson Sandra","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cardfail.2004.02.003","article-title":"Hospitalized heart failure: rates and long-term mortality","volume":"10","author":"Shahar","year":"2004","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005171","article-title":"Characteristics of acute heart failure hospitalizations based on presenting severity","volume":"12","author":"Parikh","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013Neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0025","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.161.19.2337","article-title":"Acute precipitants of congestive heart failure exacerbations","volume":"161","author":"Tsuyuki","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0030","first-page":"e32","article-title":"Drugs that may cause or exacerbate heart failure","volume":"134","author":"Page Robert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Prim. Care"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0040","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"Havakuk","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0060","series-title":"Annual Surveillance Report of Drug-Related Risks and Outcomes\u2013United States","author":"Lx","year":"2018"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2018.17091048","article-title":"Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States","volume":"175","author":"Compton","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0070","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19\u20135068, NSDUH Series H-54)","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0075","series-title":"National Drug Threat Assessment","author":"US Department of Justice Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cger.2014.04.008","article-title":"Substance abuse among older adults","volume":"30","author":"Kuerbis","year":"2014","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0085","series-title":"A Day in the Life of Older Adults: Substance Use Facts","first-page":"1","author":"Mattson","year":"2013"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003552","article-title":"National differences in trends for heart failure hospitalizations by sex and race\/ethnicity","volume":"10","author":"Ziaeian","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0095","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2013.10.032","article-title":"Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the atherosclerosis risk in communities study)","volume":"113","author":"Chang","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.111.066688","article-title":"Racial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women\u2019s Health Initiative","volume":"126","author":"Eaton","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/M13-2946","article-title":"Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study","volume":"161","author":"Kind","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1360-0443.2008.02159.x","article-title":"Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation","volume":"103","author":"Borders","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0120","series-title":"Methamphetamine","author":"NIDA","year":"2019"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0125","series-title":"Cocaine","author":"NIDA","year":"2016"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0130","series-title":"Health, United States, 2018","author":"National Center for Health Statistics","year":"2019"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jchf.2017.02.017","article-title":"Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy","volume":"5","author":"Schurer","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0145","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20367","article-title":"A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse","volume":"32","author":"Ito","year":"2009","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjmed.2019.07.017","article-title":"The impact of substance abuse on heart failure hospitalizations","volume":"133","author":"Nishimura","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjcard.2019.09.030","article-title":"Comparison of clinical characteristics and outcomes of patients with reversible versus persistent methamphetamine-associated cardiomyopathy","volume":"125","author":"Zhao","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12012-015-9350-y","article-title":"Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence","volume":"16","author":"Sliman","year":"2016","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0165","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/hrt.2011.226977","article-title":"Silent myocardial damage in cocaine addicts","volume":"97","author":"Aquaro","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0170","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0735-1097(92)90374-V","article-title":"Cardiac manifestations of cocaine abuse: a cross-sectional study of asymptomatic men with a history of long-term abuse of \u201ccrack\u201d cocaine","volume":"20","author":"Chakko","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1532-429X-16-26","article-title":"Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T","volume":"16","author":"Maceira","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000047339","article-title":"Prevalence of heart disease in asymptomatic chronic cocaine users","volume":"95","author":"Roldan","year":"2001","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2021.01.060_bb0185","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7326\/0003-4819-111-12-1039","article-title":"Reversible cardiomyopathy associated with cocaine intoxication","volume":"111","author":"Chokshi","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2021.01.060_bb0190","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0002-8703(92)90090-I","article-title":"Reversibility of cocaine-induced cardiomyopathy","volume":"124","author":"Om","year":"1992","journal-title":"Am. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732100142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732100142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:51:17Z","timestamp":1759092677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732100142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"alternative-id":["S016752732100142X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.01.060","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.01.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}